Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin

Inflammation Research

Volumn 52, Issue 10, 2003, Pages 424-427

  Denham, K J ^a   Boutsiouki, P ^a   Clough, G F ^a   Church, M K ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antihistamines; Flare; Itch; Levocetirizine; Loratadine; Skin; Wheal

Indexed keywords

DESLORATADINE; HISTAMINE; LEVOCETIRIZINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; FLARE; HUMAN; IMAGING; MALE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN MANIFESTATION; URTICARIA; VISUAL ANALOG SCALE;

ADULT; ANTI-ALLERGIC AGENTS; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERYTHEMA; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INJECTIONS, INTRADERMAL; LASER-DOPPLER FLOWMETRY; LORATADINE; MALE; PRURITUS; REGIONAL BLOOD FLOW; SKIN;

EID: 0141921950     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1193-5     Document Type: Article

References (21)

1. Davies AJ, Harindra V, McEwan A, Ghose RR. Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 1989; 298: 325.
2. Yun CH, Okerholm RA, Guengerich FP. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 1993; 21: 403-9.
3. Yumibe N, Huie K, Chen KJ, Snow M, Clement RP, Cayen MN. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6. Biochem Pharmacol 1996; 51: 165-72.
4. Devalia JL, De Vos C, Hanotte F, Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 2001; 56: 50-7.
5. Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 2001; 56: 985-8.
6. Frossard N, Melac M, Benabdesselam O, Pauli G. Consistency of the efficacy of cetirizine and ebastine on skin reactivity. Ann Allergy Asthma Immunol 1998; 80: 61-5.
7. Bayramgurler D, Bilen N, Apaydyn R, Altintas L, Sal G, Dokmeci S et al. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses. Clin Exp Dermatol 1999; 24: 407-11.
8. Grant JA, Danielson L, Rihoux JP, De Vos C. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy 1999; 54: 700-7.
9. Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung 2000; 50: 345-52.
10. Kreutner W, Hey JA, Chiu P, Barnett A. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects. Arzneimittelforschung 2000; 50: 441-8.
11. Hubert J, Moritzen V, Parks A, Radwanski E, Perentesis G, Symchowicz S et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res 1988; 16: 50-60.
12. Clough GF, Voegeli D, Bennett A, Church MK. A study of the inflammatory response in human skin using scanning laser Doppler imaging. International Journal of Microcirculation and Clinical Experimentalogy 1997; 17: 211.
13. 1-antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol 1998; 138: 806-14.
14. Schering Corporation. Clarinex (Desloratadine) Tablets Approval package. US Food and Drug Administration, Center for Drug Evaluation and Research, Application Number 21-165, 2001.
15. Benedetti MS, Plisnier M, Kaise J, Maier L, Baltes E, Arendt C et al. Absorption, distribution, metabolism and excretion of [14C] levocetirizine, the Renantiomer of cetirizine, in healthy volunteers. Eur J Clin Pharmacol 2001; 57: 571-82.
16. Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo - a microdialysis study. J Invest Dermatol 1995; 105: 50.
17. 1-antagonists: receptor affinity versus selectivity. Inflamm Res 2003; 52 Suppl 1: S49-S50.
18. Baltes E, Coupez R, Giezek H, Voss G, Meyerhoff C, Strolin BM. Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 2001; 15: 269-77.
19. Henz BM. The pharmacologic profile of desloratadine: a review. Allergy 2001; 56 Suppl 65: 7-13.
20. Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE et al. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. Eur J Pharmacol 2002; 449: 229-37.
21. 3H]levocetirizine to cloned human H1-histamine receptors expressed in CHO cells. Inflamm Res 2002; 51 Suppl 1: S77-S78.